Vitamin D3 and analogs thereof for treating alopecia
US11305016B2 · kind B2 · utility
1Cited by
13References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 16, 2018 |
| Grant date | Apr 19, 2022 |
| Priority date | — |
| Expiry date | Jan 16, 2038 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61Q7/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides methods and pharmaceutical compositions for preventing or treating alopecia, such as chemotherapy-induced alopecia (CIA). The pharmaceutical compositions of the invention comprises an effective amount of a vitamin D compound in a formulation that topically delivers the vitamin D compound to the epidermis layer but substantially avoids the dermis layer. In chemotherapy patients, the pharmaceutical compositions of the invention can be administered either before or concurrent with the chemotherapy medication.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.